Company intelligence / Profile preview

Bonyf

Schaan, Liechtenstein

Ownership: Private
Employees: ~30
Development stage: Other

Overview

Bonyf is a healthcare company specializing in the development, manufacturing, and marketing of next-generation oral hygiene products and infection prevention solutions. Headquartered in Liechtenstein, the company focuses on oral biofilm control, particularly in denture care and the treatment of inflammatory oral conditions such as periodontitis. Its product portfolio includes the Nitradine disinfection range for medical devices and PerioTabs for periodontal therapy. Bonyf is publicly traded on the Euronext Growth Paris exchange and maintains a global distribution network for its patented oral health technologies.

Therapeutic areas: GastroenterologyInfectious Diseases
Modalities: DeviceTopical formulation
Industry: Consumable Medical Devices

Beyond the preview

Go deeper on Bonyf.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bonyf.

Explore the full profile